Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 304-308, December 2008

Role of Bladder Capacity in Assessing the Effectiveness of Antimuscarinic Agents on Nocturia in Patients with Overactive Bladders

Department of Urology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan

Received 4 January 2008; received in revised form 24 January 2008; accepted 4 April 2008.

Article Outline

Abstract 

Objective

The aim of this study was to evaluate the effectiveness of oxybutynin in the treatment of nocturia in patients with overactive bladders (OAB) and to assess predictive factors for the responses to oxybutynin.

Patients and Methods

Patients with symptoms of OAB and nocturia for more than 3 months were enrolled. A 2.5 mg dose of oxybutynin was given twice daily for 1 week after a baseline study that included a self-administered nocturia questionnaire, uroflowmetry, and frequency/volume chart. Outcome analysis included changes in nocturia episodes, uroflowmetry, and post-void residual urine. Patients were stratified according to a nocturia index (Ni), nocturnal polyuria index (NPi), and nocturnal bladder capacity index (NBCi).

Results

A total of 59 patients were eligible for analysis. After 1 week of treatment with oxybutynin, the mean number of nocturia episodes had reduced from 2.7 ± 1.3 to 2.3 ± 1.1 (p < 0.01). There were no statistically significant differences in the mean reduction of nocturia episodes between the subgroup of patients with NPi ≤ 0.35 and those with NPi > 0.35 (−0.4 vs. −0.3, p = 0.34, ANCOVA). Reduction in number of nocturia episodes was more significant in patients with Ni ≤ 1.5 than in those with Ni > 1.5 (−0.9 vs. −0.2, p = 0.03, ANCOVA), and in patients with NBCi > 2 than in those with NBCi ≤ 2 (−1.1 vs. −0.2, p = 0.01, ANCOVA).

Conclusion

Ni and NBCi are good predicting factors for the effects of antimuscarinic agents on nocturia in patients with OAB.

Keywords:  Antimuscarinic , Nocturia , Overactive bladder

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Coyne KS , Zhou Z , Bhattacharyya SK , Thompson CL , Dhawan R , Versi E . The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA . BJU Int . 2003;92:948–954
  2. Chapple C , Steers W , Norton P , et al.   A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder . BJU Int . 2005;95:993–1001
  3. Brubaker L , Fitzgerald MP . Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms . Int Urogynecol J Pelvic Floor Dysfunct . 2007;18:737–741
  4. van Kerrebroeck P , Abrams P , Chaikin D , et al.   The standardisation of terminology in nocturia: report from the standardisation Sub-committee of the International Continence Society . Neurourol Urodyn . 2002;21:179–183
  5. Weiss JP , Blaivas JG , Stember DS , Chaikin DC . Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices . Neurourol Urodyn . 1999;18:559–565
  6. Asplund R , Sundberg B , Bengtsson P . Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study . Br J Urol . 1998;82:642–646
  7. Rembratt A , Norgaard JP , Andersson KE . Differences between nocturics and non-nocturics in voiding patterns: an analysis of frequency-volume charts from community-dwelling elderly . BJU Int . 2003;91:45–50
  8. Weiss JP , Blaivas JG , Jones M , Wang JT , Guan Z . Age related pathogenesis of nocturia in patients with overactive bladder . J Urol . 2007;178:548–551
  9. Asplund R . Pharmacotherapy for nocturia in the elderly patient . Drugs Aging . 2007;24:325–343
  10. Kreder KJ , Brubaker L , Mainprize T . Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone . BJU Int . 2003;92:418–421
  11. Johnson TM , Burgio KL , Redden DT , Wright KC , Goode PS . Effects of behavioral and drug therapy on nocturia in older incontinent women . J Am Geriatr Soc . 2005;53:846–850
  12. Reiz JL , Salem P , Darke AC . Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutynin . J Clin Pharmacol . 2007;47:351–357
  13. Locher JL , Goode PS , Roth DL , Worrell RL , Burgio KL . Reliability assessment of the bladder diary for urinary incontinence in older women . J Gerontol A Biol Sci Med Sci . 2001;56:M32–M35
  14. Ku JH , Jeong IG , Lim DJ , Byun SS , Paick JS , Oh SJ . Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: prospective assessment of patient compliance and burden . Neurourol Urodyn . 2004;23:331–335
  15. van Melick HH , Gisolf KW , Eckhardt MD , van Venrooij GE , Boon TA . One 24-hour frequency-volume chart in a woman with objective urinary motor urge incontinence is sufficient . Urology . 2001;58:188–192
  16. Dmochowski RR , Sanders SW , Appell RA , Nitti VW , Davila GW . Bladder-health diaries: an assessment of 3-day vs 7-day entries . BJU Int . 2005;96:1049–1054

PII: S1016-3190(08)60055-5

doi:10.1016/S1016-3190(08)60055-5

Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 304-308, December 2008

Article Tools